Kiwa Bio-Tech Products Group Corporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 40.089 million compared to USD 30.650 million a year ago. Operating loss was USD 1.185 million compared to operating Income of USD 2.589 million a year ago. Net loss was USD 6.635 million compared to net income of USD 343,821 a year ago. Basic loss per share from continuing operations was USD 0.29 compared to basic earnings per share from continuing operations of USD 0.02 a year ago.